Early stage follicular lymphoma, current management and controversies

Current Opinion in Oncology

Volumn 24, Issue 5, 2012, Pages 475-479

  Jacobson, Caron A ^a   Freedman, Arnold S ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

chemoimmunotherapy; follicular lymphoma; minimal residual disease; observation; radiation therapy

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN BCL 2;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CANCER CHEMOTHERAPY; FOLLICULAR LYMPHOMA; GENE REARRANGEMENT; HUMAN; IMMUNOTHERAPY; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; UNITED STATES;

COMBINED MODALITY THERAPY; HUMANS; LYMPHOMA, FOLLICULAR; NEOPLASM STAGING;

EID: 84865461549     PISSN: 10408746     EISSN: 1531703X     Source Type: Journal    
DOI: 10.1097/CCO.0b013e328356898b     Document Type: Review

References (27)

1. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood. 1997; 89:3909-3918.
2. Anderson T, Chabner BA, Young RC, et al. Malignant lymphoma. The histology and staging of 473 patients at the National Cancer Institute. Cancer 1982; 50:2699-2707. (Pubitemid 13220772)
3. Pugh TJ, Ballonoff A, Newman F, Rabinovitch R. Improved survival in patients with early stage low-grade follicular lymphoma treated with radiation: a surveillance, epidemiology, and end results database analysis. Cancer 2010; 116:3843-3851.
4. Guadagnolo BA, Li S, Neuberg D, et al. Long-term outcome and mortality trends in early-stage, grade 1-2 follicular lymphoma treated with radiation therapy. Int J Radiat Oncol Biol Phys 2006; 64:928-934. (Pubitemid 43183595)
5. Friedberg JW, Taylor MD, Cerhan JR, et al. Follicular lymphoma in the United States: first report of the national LymphoCare study. J Clin Oncol 2009; 27:1202-1208.
6. Mori M, Kobayashi Y, Maeshima AM, et al. The indolent course and high incidence of t(14;18) in primary duodenal follicular lymphoma. Ann Oncol 2010; 21:1500-1505.
7. Yokoyama MTY, Takeuchi K, et al. Primary intestinal follicular lymphoma: a single institution study of 40 cases in the rituximab era. Ann Oncol 2011; 22 (Suppl 4):a317.
8. Lorsbach RB, Shay-Seymore D, Moore J, et al. Clinicopathologic analysis of follicular lymphoma occurring in children. Blood 2002; 99:1959-1964. (Pubitemid 34525475)
9. Wilder RB, Jones D, Tucker SL, et al. Long-term results with radiotherapy for Stage I-II follicular lymphomas. Int J Radiat Oncol Biol Phys 2001; 51:1219-1227. (Pubitemid 33116314)
10. Campbell BA, Voss N, Woods R, et al. Long-term outcomes for patients with limited stage follicular lymphoma: involved regional radiotherapy versus involved node radiotherapy. Cancer 2010; 116:3797-3806.
11. MacManus MP, Hoppe RT. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. J Clin Oncol 1996; 14:1282-1290. (Pubitemid 26105537)
12. MacManus MP, Rainer Bowie CA, Hoppe RT. What is the prognosis for patients who relapse after primary radiation therapy for early-stage low-grade follicular lymphoma? Int J Radiat Oncol Biol Phys 1998; 42:365-371. (Pubitemid 28502784)
13. Chen MG, Prosnitz LR, Gonzalez-Serva A, Fischer DB. Results of radiotherapy in control of stage I and II non-Hodgkin's lymphoma. Cancer 1979; 43:1245-1254. (Pubitemid 9180290)
14. Fung CY, Tarbell NJ, Lucarelli MJ, et al. Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes. Int J Radiat Oncol Biol Phys 2003; 57:1382-1391. (Pubitemid 37443980)
15. McLaughlin P, Fuller LM, Velasquez WS, et al. Stage I-II follicular lymphoma. Treatment results for 76 patients. Cancer 1986; 58:1596-1602. (Pubitemid 16032135)
16. Englehard M, Unterhalt M, Hansmann M, Stuschke M. Follicular lymphoma: curability by radiotherapy in limited stage nodal disease? Updated results of a randomized trial. Ann Oncol 2011; 22 (Suppl 4):a027.
17. Lybeert ML, Meerwaldt JH, Deneve W. Long-term results of low dose total body irradiation for advanced non-Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 1987; 13:1167-1172.
18. Murtha AD, Rupnow BA, Hansosn J, et al. Long-term follow-up of patients with Stage III follicular lymphoma treated with primary radiotherapy at Stanford University. Int J Radiat Oncol Biol Phys 2001; 49:3-15. (Pubitemid 32041272)
19. Lowry L, Smith P, Qian W, et al. Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. Radiother Oncol 2011; 100:86-92.
20. Kelsey SM, Newland AC, Hudson GV, Jelliffe AM. A British National Lymphoma Investigation randomised trial of single agent chlorambucil plus radiotherapy versus radiotherapy alone in low grade, localised non-Hodgkins lymphoma. Med Oncol 1994; 11:19-25. (Pubitemid 24266261)
21. Monfardini S, Banfi A, Bonadonna G, et al. Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 1980; 6:125-134. (Pubitemid 10156740)
22. Toonkel LM, Fuller LM, Gamble JF, et al. Laparotomy staged I and II non-Hodgkin's lymphomas: preliminary results of radiotherapy and adjunctive chemotherapy. Cancer 1980; 45:249-260. (Pubitemid 10212187)
23. Friedberg J, Byrtek M, Link B, et al. Should radiation therapy (XRT) be the standard therapeutic approach for stage I follicular lymphoma (FL)? A comparative effectiveness analysis of the National Lymphocare Study (NLCS). Ann Oncol 2011; 22 (Suppl 4):a026.
24. +/-rituximab. Ann Oncol 2011; 22 (Suppl 4):a303.
25. Ruella MFA, Di Russo A, et al. Rituximab followed by involved field radiotherapy (IF-RT) in stage I-II follicular lymphoma (FL): long term results. Blood 2011; 118:a3699.
26. Advani R, Rosenberg SA, Horning SJ. Stage I and II follicular non-Hodgkin's lymphoma: long-term follow-up of no initial therapy. J Clin Oncol 2004; 22:1454-1459. (Pubitemid 41103628)
27. Soubeyran P, Eghbali H, Trojani M, et al. Is there any place for a wait-and-see policy in stage I0 follicular lymphoma? A study of 43 consecutive patients in a single center. Ann Oncol 1996; 7:713-718. (Pubitemid 26323544)